Cargando…
Microglia depletion as a therapeutic strategy: friend or foe in multiple sclerosis models?
Multiple sclerosis is a chronic central nervous system demyelinating disease whose onset and progression are driven by a combination of immune dysregulation, genetic predisposition, and environmental factors. The activation of microglia and astrocytes is a key player in multiple sclerosis immunopath...
Autores principales: | Wies Mancini, Victoria Sofia Berenice, Di Pietro, Anabella Ayelen, Pasquini, Laura Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396475/ https://www.ncbi.nlm.nih.gov/pubmed/35900401 http://dx.doi.org/10.4103/1673-5374.346538 |
Ejemplares similares
-
Microglia in Multiple Sclerosis: Friend or Foe?
por: Guerrero, Brooke L., et al.
Publicado: (2020) -
Vaccination in Multiple Sclerosis: Friend or Foe?
por: Zrzavy, Tobias, et al.
Publicado: (2019) -
Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?
por: Vasileiadis, Georgios K., et al.
Publicado: (2018) -
Microglia: Friends or Foes in Glaucoma? A Developmental Perspective
por: Ahmad, Iqbal, et al.
Publicado: (2022) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)